Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 343 entries
Sorted by: Best Match Show Resources per page
Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease.

BMC clinical pathology

Efared B, Mazti A, Chaibou B, Atsame-Ebang G, Sidibé IS, Tahiri L, Erregad F, Hammas N, El Mrini A, El Fatemi H, Chbani L.
PMID: 28396615
BMC Clin Pathol. 2017 Apr 07;17:5. doi: 10.1186/s12907-017-0044-1. eCollection 2017.

BACKGROUND: The coexistence of Rosai-Dorfman disease (RDD) with Langerhans cell histiocytosis (LCH) is very rare, as to date only 17 cases have been reported in the english literature. The pathophysiology of this uncommon co-occurrence still remains enigmatic and a...

Cite
Efared B, Mazti A, Chaibou B, et al. Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC Clin Pathol. 2017;17:5doi: 10.1186/s12907-017-0044-1.
Efared, B., Mazti, A., Chaibou, B., Atsame-Ebang, G., Sidibé, I. S., Tahiri, L., Erregad, F., Hammas, N., El Mrini, A., El Fatemi, H., & Chbani, L. (2017). Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC clinical pathology, 175. https://doi.org/10.1186/s12907-017-0044-1
Efared, Boubacar, et al. "Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease." BMC clinical pathology vol. 17 (2017): 5. doi: https://doi.org/10.1186/s12907-017-0044-1
Efared B, Mazti A, Chaibou B, Atsame-Ebang G, Sidibé IS, Tahiri L, Erregad F, Hammas N, El Mrini A, El Fatemi H, Chbani L. Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease. BMC Clin Pathol. 2017 Apr 07;17:5. doi: 10.1186/s12907-017-0044-1. eCollection 2017. PMID: 28396615; PMCID: PMC5383940.
Copy Download .nbib Format: NLM
Physical properties of cobia (Rachycentron canadum) surimi: effect of washing cycle at different salt concentrations.

Journal of food science and technology

Hamzah N, Sarbon NM, Amin AM.
PMID: 26243898
J Food Sci Technol. 2015 Aug;52(8):4773-84. doi: 10.1007/s13197-014-1622-1. Epub 2014 Oct 30.

This study aimed to determine the effects of 2-5 wash cycles and the addition of tetrasodium pyrophosphate (TSPP) (0 %, 0.05 Surimi% and 0.1 % w/w)-with or without the addition of 0.4 % calcium chloride (CaCl2)-on the physical properties...

Cite
Hamzah N, Sarbon NM, Amin AM. Physical properties of cobia (Rachycentron canadum) surimi: effect of washing cycle at different salt concentrations. J Food Sci Technol. 2014;52(8):4773-84doi: 10.1007/s13197-014-1622-1.
Hamzah, N., Sarbon, N. M., & Amin, A. M. (2015). Physical properties of cobia (Rachycentron canadum) surimi: effect of washing cycle at different salt concentrations. Journal of food science and technology, 52(8), 4773-84. https://doi.org/10.1007/s13197-014-1622-1
Hamzah, N, et al. "Physical properties of cobia (Rachycentron canadum) surimi: effect of washing cycle at different salt concentrations." Journal of food science and technology vol. 52,8 (2015): 4773-84. doi: https://doi.org/10.1007/s13197-014-1622-1
Hamzah N, Sarbon NM, Amin AM. Physical properties of cobia (Rachycentron canadum) surimi: effect of washing cycle at different salt concentrations. J Food Sci Technol. 2015 Aug;52(8):4773-84. doi: 10.1007/s13197-014-1622-1. Epub 2014 Oct 30. PMID: 26243898; PMCID: PMC4519499.
Copy Download .nbib Format: NLM
A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.

Current oncology (Toronto, Ont.)

Graham C, Orr C, Bricks CS, Hopman WM, Hammad N, Ramjeesingh R.
PMID: 28050148
Curr Oncol. 2016 Dec;23(6):e583-e588. doi: 10.3747/co.23.3204. Epub 2016 Dec 21.

BACKGROUND: Proton pump inhibitors (ppis) are a commonly used medication. A limited number of studies have identified a weak-to-moderate association between ppi use and colorectal cancer (crc) risk, but none to date have identified an effect of ppi use...

Cite
Graham C, Orr C, Bricks CS, et al. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Curr Oncol. 2016;23(6):e583-e588doi: 10.3747/co.23.3204.
Graham, C., Orr, C., Bricks, C. S., Hopman, W. M., Hammad, N., & Ramjeesingh, R. (2016). A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Current oncology (Toronto, Ont.), 23(6), e583-e588. https://doi.org/10.3747/co.23.3204
Graham, C, et al. "A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival." Current oncology (Toronto, Ont.) vol. 23,6 (2016): e583-e588. doi: https://doi.org/10.3747/co.23.3204
Graham C, Orr C, Bricks CS, Hopman WM, Hammad N, Ramjeesingh R. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival. Curr Oncol. 2016 Dec;23(6):e583-e588. doi: 10.3747/co.23.3204. Epub 2016 Dec 21. PMID: 28050148; PMCID: PMC5176385.
Copy Download .nbib Format: NLM
Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications: a review.

Biomaterials research

Sheikh Z, Hamdan N, Ikeda Y, Grynpas M, Ganss B, Glogauer M.
PMID: 28593053
Biomater Res. 2017 Jun 05;21:9. doi: 10.1186/s40824-017-0095-5. eCollection 2017.

Periodontal disease is categorized by the destruction of periodontal tissues. Over the years, there have been several clinical techniques and material options that been investigated for periodontal defect repair/regeneration. The development of improved biomaterials for periodontal tissue engineering has...

Cite
Sheikh Z, Hamdan N, Ikeda Y, et al. Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications: a review. Biomater Res. 2017;21:9doi: 10.1186/s40824-017-0095-5.
Sheikh, Z., Hamdan, N., Ikeda, Y., Grynpas, M., Ganss, B., & Glogauer, M. (2017). Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications: a review. Biomaterials research, 219. https://doi.org/10.1186/s40824-017-0095-5
Sheikh, Zeeshan, et al. "Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications: a review." Biomaterials research vol. 21 (2017): 9. doi: https://doi.org/10.1186/s40824-017-0095-5
Sheikh Z, Hamdan N, Ikeda Y, Grynpas M, Ganss B, Glogauer M. Natural graft tissues and synthetic biomaterials for periodontal and alveolar bone reconstructive applications: a review. Biomater Res. 2017 Jun 05;21:9. doi: 10.1186/s40824-017-0095-5. eCollection 2017. PMID: 28593053; PMCID: PMC5460509.
Copy Download .nbib Format: NLM
Systemic therapy in incurable gastroenteropancreatic neuroendocrine tumours: a clinical practice guideline.

Current oncology (Toronto, Ont.)

Singh S, Sivajohanathan D, Asmis T, Cho C, Hammad N, Law C, Wong R, Zbuk K.
PMID: 28874893
Curr Oncol. 2017 Aug;24(4):249-255. doi: 10.3747/co.24.3634. Epub 2017 Aug 31.

PURPOSE: The purpose of the present review was to determine which antineoplastic systemic therapy is most effective in improving clinical outcomes for patients with incurable gastroenteropancreatic neuroendocrine tumours (nets).METHODS: A systematic search (2008-2016) of the literature in the medline...

Cite
Singh S, Sivajohanathan D, Asmis T, et al. Systemic therapy in incurable gastroenteropancreatic neuroendocrine tumours: a clinical practice guideline. Curr Oncol. 2017;24(4):249-255doi: 10.3747/co.24.3634.
Singh, S., Sivajohanathan, D., Asmis, T., Cho, C., Hammad, N., Law, C., Wong, R., & Zbuk, K. (2017). Systemic therapy in incurable gastroenteropancreatic neuroendocrine tumours: a clinical practice guideline. Current oncology (Toronto, Ont.), 24(4), 249-255. https://doi.org/10.3747/co.24.3634
Singh, S, et al. "Systemic therapy in incurable gastroenteropancreatic neuroendocrine tumours: a clinical practice guideline." Current oncology (Toronto, Ont.) vol. 24,4 (2017): 249-255. doi: https://doi.org/10.3747/co.24.3634
Singh S, Sivajohanathan D, Asmis T, Cho C, Hammad N, Law C, Wong R, Zbuk K. Systemic therapy in incurable gastroenteropancreatic neuroendocrine tumours: a clinical practice guideline. Curr Oncol. 2017 Aug;24(4):249-255. doi: 10.3747/co.24.3634. Epub 2017 Aug 31. PMID: 28874893; PMCID: PMC5576461.
Copy Download .nbib Format: NLM
Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma.

Current oncology (Toronto, Ont.)

Wang A, Ramjeesingh R, Chen CH, Hurlbut D, Hammad N, Mulligan LM, Nicol C, Feilotter HE, Davey S.
PMID: 27330354
Curr Oncol. 2016 Jun;23(3):e171-8. doi: 10.3747/co.23.3028. Epub 2016 Jun 09.

BACKGROUND: Epithelial cell adhesion molecule (epcam) is a multifunctional transmembrane glycoprotein expressed on both normal epithelium and epithelial neoplasms such as gastric, breast, and renal carcinomas. Recent studies have proposed that the proteolytic cleavage of the intracellular domain of...

Cite
Wang A, Ramjeesingh R, Chen CH, et al. Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma. Curr Oncol. 2016;23(3):e171-8doi: 10.3747/co.23.3028.
Wang, A., Ramjeesingh, R., Chen, C. H., Hurlbut, D., Hammad, N., Mulligan, L. M., Nicol, C., Feilotter, H. E., & Davey, S. (2016). Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma. Current oncology (Toronto, Ont.), 23(3), e171-8. https://doi.org/10.3747/co.23.3028
Wang, A, et al. "Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma." Current oncology (Toronto, Ont.) vol. 23,3 (2016): e171-8. doi: https://doi.org/10.3747/co.23.3028
Wang A, Ramjeesingh R, Chen CH, Hurlbut D, Hammad N, Mulligan LM, Nicol C, Feilotter HE, Davey S. Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinoma. Curr Oncol. 2016 Jun;23(3):e171-8. doi: 10.3747/co.23.3028. Epub 2016 Jun 09. PMID: 27330354; PMCID: PMC4900837.
Copy Download .nbib Format: NLM
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease.

Current oncology (Toronto, Ont.)

Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, Chen E, Porter G, Goel R, Villeneuve J, Sundaresan S, Asselah J, Biagi J, Jonker D, Dawson L, Letourneau R, Rother M, Maroun J, Thirlwell M, Hussein M, Tehfe M, Perrin N, Michaud N, Hammad N, Champion P, Rajan R, Burkes R, Barrette S, Welch S, Yarom N, Asmis T.
PMID: 20651901
Curr Oncol. 2010 Jun;17(3):70-7. doi: 10.3747/co.v17i3.610.

The annual Eastern Canadian Colorectal Cancer Consensus Conference was held in Montreal, Quebec, October 22-24, 2009. Health care professionals involved in the care of patients with colorectal cancer participated in presentation and discussion sessions for the purposes of developing...

Cite
Vickers M, Samson B, Colwell B, et al. Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol. 2010;17(3):70-7doi: 10.3747/co.v17i3.610.
Vickers, M., Samson, B., Colwell, B., Cripps, C., Jalink, D., El-Sayed, S., Chen, E., Porter, G., Goel, R., Villeneuve, J., Sundaresan, S., Asselah, J., Biagi, J., Jonker, D., Dawson, L., Letourneau, R., Rother, M., Maroun, J., Thirlwell, M., Hussein, M., Tehfe, M., Perrin, N., Michaud, N., Hammad, N., Champion, P., Rajan, R., Burkes, R., Barrette, S., Welch, S., Yarom, N., & Asmis, T. (2010). Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Current oncology (Toronto, Ont.), 17(3), 70-7. https://doi.org/10.3747/co.v17i3.610
Vickers, M, et al. "Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease." Current oncology (Toronto, Ont.) vol. 17,3 (2010): 70-7. doi: https://doi.org/10.3747/co.v17i3.610
Vickers M, Samson B, Colwell B, Cripps C, Jalink D, El-Sayed S, Chen E, Porter G, Goel R, Villeneuve J, Sundaresan S, Asselah J, Biagi J, Jonker D, Dawson L, Letourneau R, Rother M, Maroun J, Thirlwell M, Hussein M, Tehfe M, Perrin N, Michaud N, Hammad N, Champion P, Rajan R, Burkes R, Barrette S, Welch S, Yarom N, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol. 2010 Jun;17(3):70-7. doi: 10.3747/co.v17i3.610. PMID: 20651901; PMCID: PMC2880907.
Copy Download .nbib Format: NLM
Alteration in the capacities of carcinogen metabolizing system of mouse-livers during pretreatment with various antineoplastic agents.

Oncology reports

Mostafa M, Chalvardjian K, Lami H, Badawi A, Hamzah R.
PMID: 21607420
Oncol Rep. 1994 May;1(3):651-6. doi: 10.3892/or.1.3.651.

The effect of treatment with antineoplastic drugs on the modification of the carcinog en-metabolizing capacity was studied in mice liver microsomes at different durations as a single and as a repeated dose treatment. It is generally demonstrated that there...

Cite
Mostafa M, Chalvardjian K, Lami H, et al. Alteration in the capacities of carcinogen metabolizing system of mouse-livers during pretreatment with various antineoplastic agents. Oncol Rep. 1994;1(3):651-6doi: 10.3892/or.1.3.651.
Mostafa, M., Chalvardjian, K., Lami, H., Badawi, A., & Hamzah, R. (1994). Alteration in the capacities of carcinogen metabolizing system of mouse-livers during pretreatment with various antineoplastic agents. Oncology reports, 1(3), 651-6. https://doi.org/10.3892/or.1.3.651
Mostafa, M, et al. "Alteration in the capacities of carcinogen metabolizing system of mouse-livers during pretreatment with various antineoplastic agents." Oncology reports vol. 1,3 (1994): 651-6. doi: https://doi.org/10.3892/or.1.3.651
Mostafa M, Chalvardjian K, Lami H, Badawi A, Hamzah R. Alteration in the capacities of carcinogen metabolizing system of mouse-livers during pretreatment with various antineoplastic agents. Oncol Rep. 1994 May;1(3):651-6. doi: 10.3892/or.1.3.651. PMID: 21607420.
Copy Download .nbib Format: NLM
Ethyl 1-(2-hy-droxy-eth-yl)-2-propyl-1H-benzimidazole-5-carboxyl-ate.

Acta crystallographica. Section E, Structure reports online

Hamzah N, Ngah N, Abd Hamid S, Abdul Rahim AS.
PMID: 22058794
Acta Crystallogr Sect E Struct Rep Online. 2011 Oct 01;67:o2704. doi: 10.1107/S1600536811037421. Epub 2011 Sep 30.

In the title compound, C(15)H(20)N(2)O(3), the benzimidazole ring is essentially planar, with a maximum deviation from the mean plane of 0.012 (1) Å. The crystal structure is stabilized by inter-molecular O-H⋯N hydrogen bonds, forming centrosymmetric dimers, which are connected...

Cite
Hamzah N, Ngah N, Abd Hamid S, et al. Ethyl 1-(2-hy-droxy-eth-yl)-2-propyl-1H-benzimidazole-5-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online. 2011;67:o2704doi: 10.1107/S1600536811037421.
Hamzah, N., Ngah, N., Abd Hamid, S., & Abdul Rahim, A. S. (2011). Ethyl 1-(2-hy-droxy-eth-yl)-2-propyl-1H-benzimidazole-5-carboxyl-ate. Acta crystallographica. Section E, Structure reports online, 67o2704. https://doi.org/10.1107/S1600536811037421
Hamzah, Nurasyikin, et al. "Ethyl 1-(2-hy-droxy-eth-yl)-2-propyl-1H-benzimidazole-5-carboxyl-ate." Acta crystallographica. Section E, Structure reports online vol. 67 (2011): o2704. doi: https://doi.org/10.1107/S1600536811037421
Hamzah N, Ngah N, Abd Hamid S, Abdul Rahim AS. Ethyl 1-(2-hy-droxy-eth-yl)-2-propyl-1H-benzimidazole-5-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online. 2011 Oct 01;67:o2704. doi: 10.1107/S1600536811037421. Epub 2011 Sep 30. PMID: 22058794; PMCID: PMC3201285.
Copy Download .nbib Format: NLM
Deep-fried keropok lekors Increase Oxidative Instability in Cooking Oils.

The Malaysian journal of medical sciences : MJMS

Kamisah Y, Shamil S, Nabillah MJ, Kong SY, Hamizah NA, Qodriyah HM, Nur Azlina MF, Azman A, Jaarin K.
PMID: 23613649
Malays J Med Sci. 2012 Oct;19(4):57-62.

BACKGROUND: This study was performed to compare the oxidative quality of repeatedly heated palm and soybean oils, which were used to fry keropok lekors and potato chips.METHODS: A kilogramme of keropok lekors or potato chips was fried in 2.5...

Cite
Kamisah Y, Shamil S, Nabillah MJ, et al. Deep-fried keropok lekors Increase Oxidative Instability in Cooking Oils. Malays J Med Sci. 2012;19(4):57-62
Kamisah, Y., Shamil, S., Nabillah, M. J., Kong, S. Y., Hamizah, N. A., Qodriyah, H. M., Nur Azlina, M. F., Azman, A., & Jaarin, K. (2012). Deep-fried keropok lekors Increase Oxidative Instability in Cooking Oils. The Malaysian journal of medical sciences : MJMS, 19(4), 57-62.
Kamisah, Yusof, et al. "Deep-fried keropok lekors Increase Oxidative Instability in Cooking Oils." The Malaysian journal of medical sciences : MJMS vol. 19,4 (2012): 57-62.
Kamisah Y, Shamil S, Nabillah MJ, Kong SY, Hamizah NA, Qodriyah HM, Nur Azlina MF, Azman A, Jaarin K. Deep-fried keropok lekors Increase Oxidative Instability in Cooking Oils. Malays J Med Sci. 2012 Oct;19(4):57-62. PMID: 23613649; PMCID: PMC3629680.
Copy Download .nbib Format: NLM
Energy-Efficient Fuzzy-Logic-Based Clustering Technique for Hierarchical Routing Protocols in Wireless Sensor Networks.

Sensors (Basel, Switzerland)

Hamzah A, Shurman M, Al-Jarrah O, Taqieddin E.
PMID: 30700022
Sensors (Basel). 2019 Jan 29;19(3). doi: 10.3390/s19030561.

In wireless sensor networks, the energy source is limited to the capacity of the sensor node's battery. Clustering in WSN can help with reducing energy consumption because transmission energy is related to the distance between sender and receiver. In...

Cite
Hamzah A, Shurman M, Al-Jarrah O, et al. Energy-Efficient Fuzzy-Logic-Based Clustering Technique for Hierarchical Routing Protocols in Wireless Sensor Networks. Sensors (Basel). 2019;19(3)doi: 10.3390/s19030561.
Hamzah, A., Shurman, M., Al-Jarrah, O., & Taqieddin, E. (2019). Energy-Efficient Fuzzy-Logic-Based Clustering Technique for Hierarchical Routing Protocols in Wireless Sensor Networks. Sensors (Basel, Switzerland), 19(3), . https://doi.org/10.3390/s19030561
Hamzah, Abdulmughni, et al. "Energy-Efficient Fuzzy-Logic-Based Clustering Technique for Hierarchical Routing Protocols in Wireless Sensor Networks." Sensors (Basel, Switzerland) vol. 19,3 (2019). doi: https://doi.org/10.3390/s19030561
Hamzah A, Shurman M, Al-Jarrah O, Taqieddin E. Energy-Efficient Fuzzy-Logic-Based Clustering Technique for Hierarchical Routing Protocols in Wireless Sensor Networks. Sensors (Basel). 2019 Jan 29;19(3). doi: 10.3390/s19030561. PMID: 30700022; PMCID: PMC6387035.
Copy Download .nbib Format: NLM
Serum biomarkers to predict risk of testicular and penile cancer in AMORIS.

Ecancermedicalscience

Ghoshal A, Garmo H, Arthur R, Hammar N, Jungner I, Malmström H, Lambe M, Walldius G, Hemelrijck MV.
PMID: 28900475
Ecancermedicalscience. 2017 Aug 23;11:762. doi: 10.3332/ecancer.2017.762. eCollection 2017.

PURPOSE: To evaluate the association between commonly measured serum biomarkers of inflammation and penile and testicular cancer risk in the Swedish Apolipoprotein-related MORtality RISk (AMORIS) study.MATERIALS AND METHODS: A total of 205,717 subjects had baseline measurements of C-reactive protein,...

Cite
Ghoshal A, Garmo H, Arthur R, et al. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS. Ecancermedicalscience. 2017;11:762doi: 10.3332/ecancer.2017.762.
Ghoshal, A., Garmo, H., Arthur, R., Hammar, N., Jungner, I., Malmström, H., Lambe, M., Walldius, G., & Hemelrijck, M. V. (2017). Serum biomarkers to predict risk of testicular and penile cancer in AMORIS. Ecancermedicalscience, 11762. https://doi.org/10.3332/ecancer.2017.762
Ghoshal, Arunangshu, et al. "Serum biomarkers to predict risk of testicular and penile cancer in AMORIS." Ecancermedicalscience vol. 11 (2017): 762. doi: https://doi.org/10.3332/ecancer.2017.762
Ghoshal A, Garmo H, Arthur R, Hammar N, Jungner I, Malmström H, Lambe M, Walldius G, Hemelrijck MV. Serum biomarkers to predict risk of testicular and penile cancer in AMORIS. Ecancermedicalscience. 2017 Aug 23;11:762. doi: 10.3332/ecancer.2017.762. eCollection 2017. PMID: 28900475; PMCID: PMC5574660.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 343 entries